Application 207653
- Type
- ANDA
- Sponsor
- INVENTIA HEALTHCARE PRIVATE LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ROSUVASTATIN CALCIUM | ROSUVASTATIN CALCIUM | UNKNOWN | UNKNOWN | No | No |
| 002 | ROSUVASTATIN CALCIUM | ROSUVASTATIN CALCIUM | TABLET;ORAL | 10MG | No | No |
| 003 | ROSUVASTATIN CALCIUM | ROSUVASTATIN CALCIUM | TABLET;ORAL | 20MG | No | No |
| 004 | ROSUVASTATIN CALCIUM | ROSUVASTATIN CALCIUM | TABLET;ORAL | 40MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A207653-001 | ROSUVASTATIN CALCIUM | ROSUVASTATIN CALCIUM | EQ 5MG BASE | TABLET / ORAL | 2021-02-05 | ||
| A207653-002 | ROSUVASTATIN CALCIUM | ROSUVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | 2021-02-05 | ||
| A207653-003 | ROSUVASTATIN CALCIUM | ROSUVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | 2021-02-05 | ||
| A207653-004 | ROSUVASTATIN CALCIUM | ROSUVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | 2021-02-05 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207653-001 | ROSUVASTATIN CALCIUM | EQ 5MG BASE | TABLET / ORAL | 2021-02-05 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207653-002 | ROSUVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | 2021-02-05 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207653-003 | ROSUVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | 2021-02-05 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207653-004 | ROSUVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | 2021-02-05 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207653-001 | ROSUVASTATIN CALCIUM | EQ 5MG BASE | TABLET / ORAL | 2021-02-05 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207653-002 | ROSUVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | 2021-02-05 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207653-003 | ROSUVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | 2021-02-05 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207653-004 | ROSUVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | 2021-02-05 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A207653-001 | ROSUVASTATIN CALCIUM | EQ 5MG BASE | TABLET / ORAL | 2021-02-05 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A207653-002 | ROSUVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | 2021-02-05 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A207653-003 | ROSUVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | 2021-02-05 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A207653-004 | ROSUVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | 2021-02-05 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207653-001 | ROSUVASTATIN CALCIUM | EQ 5MG BASE | TABLET / ORAL | 2021-02-05 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207653-002 | ROSUVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | 2021-02-05 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207653-003 | ROSUVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | 2021-02-05 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207653-004 | ROSUVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | 2021-02-05 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A207653-001 | ROSUVASTATIN CALCIUM | EQ 5MG BASE | TABLET / ORAL | 2021-02-05 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A207653-002 | ROSUVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | 2021-02-05 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A207653-003 | ROSUVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | 2021-02-05 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A207653-004 | ROSUVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | 2021-02-05 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A207653-001 | ROSUVASTATIN CALCIUM | EQ 5MG BASE | TABLET / ORAL | 2021-02-05 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A207653-002 | ROSUVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | 2021-02-05 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A207653-003 | ROSUVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | 2021-02-05 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A207653-004 | ROSUVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | 2021-02-05 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A207653-001 | ROSUVASTATIN CALCIUM | EQ 5MG BASE | TABLET / ORAL | 2021-02-05 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A207653-002 | ROSUVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | 2021-02-05 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A207653-003 | ROSUVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | 2021-02-05 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A207653-004 | ROSUVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | 2021-02-05 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A207653-001 | ROSUVASTATIN CALCIUM | EQ 5MG BASE | TABLET / ORAL | 2021-02-05 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A207653-002 | ROSUVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | 2021-02-05 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A207653-003 | ROSUVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | 2021-02-05 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A207653-004 | ROSUVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | 2021-02-05 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A207653-001 | ROSUVASTATIN CALCIUM | EQ 5MG BASE | TABLET / ORAL | 2021-02-05 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A207653-002 | ROSUVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | 2021-02-05 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A207653-003 | ROSUVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | 2021-02-05 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A207653-004 | ROSUVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | 2021-02-05 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A207653-001 | ROSUVASTATIN CALCIUM | EQ 5MG BASE | TABLET / ORAL | 2021-02-05 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A207653-002 | ROSUVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | 2021-02-05 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A207653-003 | ROSUVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | 2021-02-05 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A207653-004 | ROSUVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | 2021-02-05 | 4b0b4de00fa7… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A207653-001 | AB | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A207653-002 | AB | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A207653-003 | AB | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A207653-004 | AB | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A207653-001 | AB | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | A207653-002 | AB | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | A207653-003 | AB | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | A207653-004 | AB | 1 | 5aa47cf7b7d7… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Rosuvastatin Calcium | ROSUVASTATIN CALCIUM | Proficient Rx LP | a9478b12-89d2-42a4-a310-707a87ef43d7 | 2022-08-01 | Warnings, Adverse reactions | Rosuvastatin Calcium ROSUVASTATIN CALCIUM |
| Rosuvastatin Calcium | ROSUVASTATIN CALCIUM | Proficient Rx LP | 3066f572-e3db-4bf8-b9ee-bd32d9ed8c13 | 2022-06-01 | Warnings, Adverse reactions | Rosuvastatin Calcium ROSUVASTATIN CALCIUM |
| Rosuvastatin Calcium | ROSUVASTATIN CALCIUM | Proficient Rx LP | dcc22d05-cff6-42f9-b9fa-930f2084753f | 2022-05-01 | Warnings, Adverse reactions | Rosuvastatin Calcium ROSUVASTATIN CALCIUM |
| Rosuvastatin Calcium | ROSUVASTATIN CALCIUM | Proficient Rx LP | c40d5c38-3585-47ed-ad81-6ad2da91c9c8 | 2022-04-01 | Warnings, Adverse reactions | Rosuvastatin Calcium ROSUVASTATIN CALCIUM |
| Rosuvastatin calcium | ROSUVASTATIN CALCIUM | Aphena Pharma Solutions - Tennessee, LLC | a5ee9510-e691-49ec-a5cd-49e70371ee4d | 2019-01-09 | Warnings, Adverse reactions | Rosuvastatin calcium ROSUVASTATIN CALCIUM |
| Rosuvastatin calcium | ROSUVASTATIN CALCIUM | Aphena Pharma Solutions - Tennessee, LLC | 410a0a03-6751-4c3d-82bf-c7c6a4081fdd | 2018-11-13 | Warnings, Adverse reactions | Rosuvastatin calcium ROSUVASTATIN CALCIUM |
| Rosuvastatin calcium | ROSUVASTATIN CALCIUM | Aphena Pharma Solutions - Tennessee, LLC | cbef0681-705c-48fd-add9-1042658ef85d | 2018-09-12 | Warnings, Adverse reactions | Rosuvastatin calcium ROSUVASTATIN CALCIUM |
| Rosuvastatin calcium | ROSUVASTATIN CALCIUM | Aphena Pharma Solutions - Tennessee, LLC | 69dfa637-2a81-4c7e-8fef-d4b4ab4c3f25 | 2018-06-30 | Warnings, Adverse reactions | Rosuvastatin calcium ROSUVASTATIN CALCIUM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 49252-061 | ROSUVASTATIN | rosuvastatin | Inventia Healthcare Limited | ANDA | Current |
| 49252-061 | ROSUVASTATIN | rosuvastatin | Inventia Healthcare Limited | ANDA | Current |
| 49252-062 | ROSUVASTATIN | rosuvastatin | Inventia Healthcare Limited | ANDA | Current |
| 49252-062 | ROSUVASTATIN | rosuvastatin | Inventia Healthcare Limited | ANDA | Current |
| 49252-063 | ROSUVASTATIN | rosuvastatin | Inventia Healthcare Limited | ANDA | Current |
| 49252-063 | ROSUVASTATIN | rosuvastatin | Inventia Healthcare Limited | ANDA | Current |
| 49252-064 | ROSUVASTATIN | rosuvastatin | Inventia Healthcare Limited | ANDA | Current |
| 49252-064 | ROSUVASTATIN | rosuvastatin | Inventia Healthcare Limited | ANDA | Current |